For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds Protocol could become a third option for high risk, early stage cases

https://www.statnews.com/2026/05/31/prostate-cancer-hormone-therapy-cut-relapse-asco-2026/ By Angus ChenMay 31, 2026 Cancer Reporter